ArticleCancer control : journal of the Moffitt Cancer Center

Apatinib for Patients With Sorafenib-Refractory Advanced Hepatitis B Virus Related Hepatocellular Carcinoma: Results of a Pilot Study.

Yingqiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.